Article Versions Notes

Perużyńska M, Birger R, Kłos P, Kwiecień H, Struk Ł, Sośnicki JG, Lafanechère L, Droździk M. The Co-Administration of Paclitaxel with Novel Pyridine and Benzofuran Derivatives that Inhibit Tubulin Polymerisation: A Promising Anticancer Strategy. Pharmaceutics. 2025; 17(2):223. https://doi.org/10.3390/pharmaceutics17020223

Perużyńska, Magdalena, Radosław Birger, Patrycja Kłos, Halina Kwiecień, Łukasz Struk, Jacek G. Sośnicki, Laurence Lafanechère, and Marek Droździk. 2025. "The Co-Administration of Paclitaxel with Novel Pyridine and Benzofuran Derivatives that Inhibit Tubulin Polymerisation: A Promising Anticancer Strategy" Pharmaceutics 17, no. 2: 223. https://doi.org/10.3390/pharmaceutics17020223

Perużyńska, M., Birger, R., Kłos, P., Kwiecień, H., Struk, Ł., Sośnicki, J. G., Lafanechère, L., & Droździk, M. (2025). The Co-Administration of Paclitaxel with Novel Pyridine and Benzofuran Derivatives that Inhibit Tubulin Polymerisation: A Promising Anticancer Strategy. Pharmaceutics, 17(2), 223. https://doi.org/10.3390/pharmaceutics17020223